232 related articles for article (PubMed ID: 15210587)
1. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.
Jaffer FA; Tung CH; Wykrzykowska JJ; Ho NH; Houng AK; Reed GL; Weissleder R
Circulation; 2004 Jul; 110(2):170-6. PubMed ID: 15210587
[TBL] [Abstract][Full Text] [Related]
2. In vivo near-infrared imaging of fibrin deposition in thromboembolic stroke in mice.
Zhang Y; Fan S; Yao Y; Ding J; Wang Y; Zhao Z; Liao L; Li P; Zang F; Teng GJ
PLoS One; 2012; 7(1):e30262. PubMed ID: 22272319
[TBL] [Abstract][Full Text] [Related]
3. Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent.
Miserus RJ; Herías MV; Prinzen L; Lobbes MB; Van Suylen RJ; Dirksen A; Hackeng TM; Heemskerk JW; van Engelshoven JM; Daemen MJ; van Zandvoort MA; Heeneman S; Kooi ME
JACC Cardiovasc Imaging; 2009 Aug; 2(8):987-96. PubMed ID: 19679287
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis.
Kim DE; Schellingerhout D; Jaffer FA; Weissleder R; Tung CH
J Cereb Blood Flow Metab; 2005 Feb; 25(2):226-33. PubMed ID: 15678125
[TBL] [Abstract][Full Text] [Related]
5. Catalytic life of activated factor XIII in thrombi. Implications for fibrinolytic resistance and thrombus aging.
Robinson BR; Houng AK; Reed GL
Circulation; 2000 Sep; 102(10):1151-7. PubMed ID: 10973845
[TBL] [Abstract][Full Text] [Related]
6. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Imaging of Early Venous Thrombosis by 19F Magnetic Resonance Imaging With Targeted Perfluorocarbon Nanoemulsions.
Temme S; Grapentin C; Quast C; Jacoby C; Grandoch M; Ding Z; Owenier C; Mayenfels F; Fischer JW; Schubert R; Schrader J; Flögel U
Circulation; 2015 Apr; 131(16):1405-14. PubMed ID: 25700177
[TBL] [Abstract][Full Text] [Related]
8. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
Vymazal J; Spuentrup E; Cardenas-Molina G; Wiethoff AJ; Hartmann MG; Caravan P; Parsons EC
Invest Radiol; 2009 Nov; 44(11):697-704. PubMed ID: 19809344
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
van Giezen JJ; Minkema J; Bouma BN; Jansen JW
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
[TBL] [Abstract][Full Text] [Related]
10. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
[TBL] [Abstract][Full Text] [Related]
11. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
Richardson VR; Cordell P; Standeven KF; Carter AM
Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530
[TBL] [Abstract][Full Text] [Related]
13. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
Sirol M; Fuster V; Badimon JJ; Fallon JT; Moreno PR; Toussaint JF; Fayad ZA
Circulation; 2005 Sep; 112(11):1594-600. PubMed ID: 16145001
[TBL] [Abstract][Full Text] [Related]
14. Factor XIII in severe sepsis and septic shock.
Zeerleder S; Schroeder V; Lämmle B; Wuillemin WA; Hack CE; Kohler HP
Thromb Res; 2007; 119(3):311-8. PubMed ID: 16574200
[TBL] [Abstract][Full Text] [Related]
15. Factor XIIIa mediated attachment of S. aureus fibronectin-binding protein A (FnbA) to fibrin: identification of Gln103 as a major cross-linking site.
Severina E; Nunez L; Baker S; Matsuka YV
Biochemistry; 2006 Feb; 45(6):1870-80. PubMed ID: 16460033
[TBL] [Abstract][Full Text] [Related]
16. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.
Becker A; Hessenius C; Licha K; Ebert B; Sukowski U; Semmler W; Wiedenmann B; Grötzinger C
Nat Biotechnol; 2001 Apr; 19(4):327-31. PubMed ID: 11283589
[TBL] [Abstract][Full Text] [Related]
17. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms underlying the proangiogenic effect of factor XIII.
Dardik R; Loscalzo J; Eskaraev R; Inbal A
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):526-32. PubMed ID: 15618543
[TBL] [Abstract][Full Text] [Related]
19. Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis.
Mutch NJ; Koikkalainen JS; Fraser SR; Duthie KM; Griffin M; Mitchell J; Watson HG; Booth NA
J Thromb Haemost; 2010 Sep; 8(9):2017-24. PubMed ID: 20586921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
